Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins.
Eight patients with disseminated non-Hodgkin's lymphoma who failed conventional combination chemotherapy were treated with high-dose chemotherapy, a supralethal dose of total-body irradiation, and a bone marrow transplant from a normal identical twin. Seven patients experienced complete remission. Four of the seven patients (two with diffuse poorly differentiated lymphocytic lymphoma, one with composite lymphoma, and one with diffuse moderately well differentiated lymphocytic lymphoma) remain in complete unmaintained remission 12-126 mo from transplantation. One patient relapsed after 10 mo but was retreated and is alive in unmaintained complete remission 73 mo from transplantation. One patient died of Pseudomonas pneumonia while in complete remission and one patient relapsed and died of progressive lymphoma. These results demonstrate that intensive chemoradiotherapy and twin marrow transplantation can induce frequent and enduring remissions in patients with disseminated non-Hodgkin's lymphoma who have failed conventional therapy.
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002386:Cataract / Q000209:etiology; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D006098:Granulocytes; D006561:Herpes Simplex / Q000209:etiology; D006801:Humans; D007958:Leukocyte Count; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000209:etiology; D017713:Platelet Transfusion; D011247:Pregnancy; D011552:Pseudomonas Infections / Q000209:etiology; D011828:Radiation Chimera; D014427:Twins; D014430:Twins, Monozygotic
D003520:Cyclophosphamide